Global OTC Pet Medication Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global OTC Pet Medication Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Increasing pet ownership and awareness related to pet diseases or pet health have fuelled the demand for OTC pet medication. In the OTC pet medication market, companies are offering pet medicines at competitive prices through various sales channels such as drug & pharmacy stores, pet specialty stores, etc. OTC pet medications are also available through online platforms, which has become a lucrative sales channel for the OTC pet medication market.
OTC Pet Medication report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Pet Medication market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Dogs & Cats and Birds are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for OTC Pet Medication industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, OTC Pet Medication key companies include Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Merck Inc., Zoetis Inc., Elanco, Virbac SA, Vetoquinol SA and Frontline, etc. Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale are top 3 players and held % share in total in 2022.
OTC Pet Medication can be divided into Fleas & Ticks Removal, Pain Relief & Arthritis, Dewormers and Others, etc. Fleas & Ticks Removal is the mainstream product in the market, accounting for % share globally in 2022.
OTC Pet Medication is widely used in various fields, such as Dogs & Cats, Birds, Fish & Reptiles and Others, etc. Dogs & Cats provides greatest supports to the OTC Pet Medication industry development. In 2022, global % share of OTC Pet Medication went into Dogs & Cats filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Pet Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Bayer Companion Animal
Boehringer Ingelheim Animal Health
Ceva Sante Animale
Merck Inc.
Zoetis Inc.
Elanco
Virbac SA
Vetoquinol SA
Frontline
Zymox
ChloraSeb
Sulfox
Adequan
Dechra Pharmaceuticals PLC
Nutramax Laboratories, Inc.
Segment by Type
Fleas & Ticks Removal
Pain Relief & Arthritis
Dewormers
Others
Dogs & Cats
Birds
Fish & Reptiles
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the OTC Pet Medication market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, OTC Pet Medication introduction, etc. OTC Pet Medication Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of OTC Pet Medication market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
OTC Pet Medication report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Pet Medication market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Dogs & Cats and Birds are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for OTC Pet Medication industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, OTC Pet Medication key companies include Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Merck Inc., Zoetis Inc., Elanco, Virbac SA, Vetoquinol SA and Frontline, etc. Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale are top 3 players and held % share in total in 2022.
OTC Pet Medication can be divided into Fleas & Ticks Removal, Pain Relief & Arthritis, Dewormers and Others, etc. Fleas & Ticks Removal is the mainstream product in the market, accounting for % share globally in 2022.
OTC Pet Medication is widely used in various fields, such as Dogs & Cats, Birds, Fish & Reptiles and Others, etc. Dogs & Cats provides greatest supports to the OTC Pet Medication industry development. In 2022, global % share of OTC Pet Medication went into Dogs & Cats filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Pet Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Bayer Companion Animal
Boehringer Ingelheim Animal Health
Ceva Sante Animale
Merck Inc.
Zoetis Inc.
Elanco
Virbac SA
Vetoquinol SA
Frontline
Zymox
ChloraSeb
Sulfox
Adequan
Dechra Pharmaceuticals PLC
Nutramax Laboratories, Inc.
Segment by Type
Fleas & Ticks Removal
Pain Relief & Arthritis
Dewormers
Others
Segment by Application
Dogs & Cats
Birds
Fish & Reptiles
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the OTC Pet Medication market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, OTC Pet Medication introduction, etc. OTC Pet Medication Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of OTC Pet Medication market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices